Search Results - "van Haaften, Wouter T"

Peribiliary Glands Are Key in Regeneration of the Human Biliary Epithelium After Severe Bile Duct Injury by de Jong, Iris E.M., Matton, Alix P.M., van Praagh, Jasper B., van Haaften, Wouter T., Wiersema‐Buist, Janneke, van Wijk, Louise A., Oosterhuis, Dorenda, Iswandana, Raditya, Suriguga, Su, Overi, Diletta, Lisman, Ton, Carpino, Guido, Gouw, Annette S.H., Olinga, Peter, Gaudio, Eugenio, Porte, Robert J.

“…Peribiliary glands (PBG) are a source of stem/progenitor cells organized in a cellular network encircling large bile ducts. Severe cholangiopathy with loss of…”
Get full text

Intestinal Activation of pH-Sensing Receptor OGR1 [GPR68] Contributes to Fibrogenesis by Hutter, Senta, van Haaften, Wouter T, Hünerwadel, Anouk, Baebler, Katharina, Herfarth, Neel, Raselli, Tina, Mamie, Céline, Misselwitz, Benjamin, Rogler, Gerhard, Weder, Bruce, Dijkstra, Gerard, Meier, Chantal Florence, de Vallière, Cheryl, Weber, Achim, Imenez Silva, Pedro H, Wagner, Carsten A, Frey-Wagner, Isabelle, Ruiz, Pedro A, Hausmann, Martin

“…pH-sensing ovarian cancer G-protein coupled receptor-1 [OGR1/GPR68] is regulated by key inflammatory cytokines. Patients suffering from inflammatory bowel…”
Get full text

Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study by van Haaften, Wouter T., Mortensen, Joachim H., Dige, Anders K., Grønbæk, Henning, Hvas, Christian L., Bay-Jensen, Anne-Christine, Karsdal, Morten A., Olinga, Peter, Manon-Jensen, Tina, Dijkstra, Gerard

“…Anti-tumor necrosis factor (TNF) therapy is effective in inducing remission in Crohn's disease in 60% of patients. No serological biomarkers are available,…”
Get full text

Histopathologic and molecular evaluation of the Organ Procurement and Transplantation Network selection criteria for intestinal graft donation by Roskott, Anne Margot C., MD, van Haaften, Wouter T., BSc, Leuvenink, Henri G.D., PhD, Ploeg, Rutger J., MD, PhD, van Goor, Harry, PhD, Blokzijl, Tjasso, BSc, Ottens, Petra J., BSc, Dijkstra, Gerard, MD, PhD, Nieuwenhuijs, Vincent B., MD, PhD

“…Abstract Background The Organ Procurement and Transplantation Network (OPTN) has formulated criteria for the selection of donors for intestinal…”
Get full text

Long noncoding RNA H19X is a key mediator of TGF-β-driven fibrosis by Pachera, Elena, Assassi, Shervin, Salazar, Gloria A, Stellato, Mara, Renoux, Florian, Wunderlin, Adam, Blyszczuk, Przemyslaw, Lafyatis, Robert, Kurreeman, Fina, de Vries-Bouwstra, Jeska, Messemaker, Tobias, Feghali-Bostwick, Carol A, Rogler, Gerhard, van Haaften, Wouter T, Dijkstra, Gerard, Oakley, Fiona, Calcagni, Maurizio, Schniering, Janine, Maurer, Britta, Distler, Jörg Hw, Kania, Gabriela, Frank-Bertoncelj, Mojca, Distler, Oliver

“…TGF-β is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production of…”
Get full text

The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFα Treatment in Crohn’s Disease by Mortensen, Joachim H., van Haaften, Wouter T., Karsdal, Morten A., Bay-Jensen, Anne-Christine, Olinga, Peter, Grønbæk, Henning, Hvas, Christian L., Manon-Jensen, Tina, Dijkstra, Gerard, Dige, Anders

“…BACKGROUND:In Crohn’s disease (CD), 10% to 40% of patients do not respond to anti-tumor necrosis factor-α (TNFα) treatment. Currently, there are no biomarkers…”
Get full text

Early Suppression of the Serological Macrophage Activity Biomarker VICM, and not Suppression of CRP, Predicts the Response to Infliximab in Crohn's Disease Patients by Mortensen, Joachim Hog, van Haaften, Wouter T, Olesen, Majken Lindholm, Karsdal, Morten Asser, Olinga, Peter, Dijkstra, Gerard, Bay-Jensen, Anne-Christine

Get full text

Serological Biomarkers of Tissue Turnover Can Early Identify Responders to Infliximab in Crohn's Disease by Mortensen, Joachim Hog, van Haaften, Wouter T, Olesen, Majken Lindholm, Karsdal, Morten, Olinga, Peter, Bay-Jensen, Anne-Christine, Dijkstra, Gerard

Get full text

189 MMP Degraded Type III Collagen Is a Novel Serological Biomarker for Penetrating (Montreal B3) Crohn's Disease by van Haaften, Wouter T, Mortensen, Joachim Høg, Karsdal, Morten Asser, Bay-Jensen, Anne-Christine, Dijkstra, Gerard, Olinga, Peter

Get full text

Ovarian Cancer G-Protein-Coupled Receptor 1 Deficiency Protects from Fibrogenesis in the Heterotopic Transplantation Model of Intestinal Fibrosis by Hutter, Senta L, Ruiz, Pedro, Weder, Bruce, Roger, Jesus Cosin, Mamie, Céline, van Haaften, Wouter T, de Valliere, Cheryl, Rogler, Gerhard, Hausmann, Martin

Get full text

Tu1238 Fibrotic Human Precision-Cut Intestinal Slices: A New Ex Vivo Model for Established Intestinal Fibrosis by van Haaften, Wouter T, Pham, Bao Tung, Oosterhuis, Dorenda, Hofker, Hendrik S, Dijkstra, Gerard, Oling, Peter

Get full text

Sa1887 - Serological Biomarkers of Tissue Turnover Can Early Identify Responders to Infliximab in Crohn's Disease by Mortensen, Joachim Hog, van Haaften, Wouter T., Olesen, Majken Lindholm, Karsdal, Morten, Olinga, Peter, Bay-Jensen, Anne-Christine, Dijkstra, Gerard

Get full text

Long noncoding RNA H19X is a key mediator of TGF-[beta]-driven fibrosis by Pachera, Elena, Assassi, Shervin, Salazar, Gloria A, Stellato, Mara, Renoux, Florian, Wunderlin, Adam, Blyszczuk, Przemyslaw, Lafyatis, Robert, Kurreeman, Fina, de Vries-Bouwstra, Jeska, Messemaker, Tobias, Feghali-Bostwick, Carol A, Rogler, Gerhard, van Haaften, Wouter T, Dijkstra, Gerard, Oakley, Fiona, Calcagni, Maurizio, Schniering, Janine, Maurer, Britta, Distler, Jorg H.W, Kania, Gabriela, Frank-Bertoncelj, Mojca, Distler, Oliver

“…TGF-[beta] is a master regulator of fibrosis, driving the differentiation of fibroblasts into apoptosis-resistant myofibroblasts and sustaining the production…”
Get full text

Tu1875 - Ovarian Cancer G-Protein-Coupled Receptor 1 Deficiency Protects from Fibrogenesis in the Heterotopic Transplantation Model of Intestinal Fibrosis by Hutter, Senta L., Ruiz, Pedro, Weder, Bruce, Roger, Jesus Cosin, Mamie, Céline, van Haaften, Wouter T., de Valliere, Cheryl, Rogler, Gerhard, Hausmann, Martin

Get full text

Sa1886 - Early Suppression of the Serological Macrophage Activity Biomarker VICM, and not Suppression of CRP, Predicts the Response to Infliximab in Crohn's Disease Patients by Mortensen, Joachim Hog, van Haaften, Wouter T., Olesen, Majken Lindholm, Karsdal, Morten Asser, Olinga, Peter, Dijkstra, Gerard, Bay-Jensen, Anne-Christine

Get full text